Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 256

1.

Treatment of Trypanosoma cruzi infection in the undetermined phase. Experience and current guidelines of treatment in Argentina.

Sosa Estani S, Segura EL.

Mem Inst Oswaldo Cruz. 1999;94 Suppl 1:363-5. Review. No abstract available.

2.

[Treatment of Chagas' disease].

Apt W.

Rev Med Chil. 1985 Feb;113(2):162-6. Spanish. No abstract available.

PMID:
3936147
3.

[Treatment of Trypanosoma cruzi infection in the indeterminate phase: experience and current guidelines in Argentina].

Sosa Estani S, Segura EL.

Medicina (B Aires). 1999;59 Suppl 2:166-70. Review. Spanish.

PMID:
10668259
4.

Antitrypanosomal therapy for chronic Chagas' disease.

Bern C.

N Engl J Med. 2011 Jun 30;364(26):2527-34. doi: 10.1056/NEJMct1014204. Review. No abstract available.

PMID:
21714649
5.

Nifurtimox chemotherapy: collateral effects in treated Trypanosoma cruzi infected patients.

Murcia L, Carrilero B, Albajar Viñas P, Segovia M.

Rev Esp Quimioter. 2012 Mar;25(1):74-5. No abstract available.

6.

[Allopurinol in the treatment of chronic Chagas' disease].

Meirovich CI, Montrull HL, Gallerano RH, Sosa RR.

Arq Bras Cardiol. 1985 Sep;45(3):217-23. Spanish. No abstract available.

PMID:
3939099
7.

Etiological treatment for infection by Trypanosoma cruzi.

Amato Neto V.

Mem Inst Oswaldo Cruz. 1999;94 Suppl 1:337-9. No abstract available.

8.
9.

Trypanocidal nitroarene treatment of experimental Trypanosoma cruzi infection does not prevent progression of chronic-phase heart lesions in rabbits.

Teixeira AR, Cunha Neto E, Rizzo LV, Silva R.

J Infect Dis. 1990 Dec;162(6):1420. No abstract available.

PMID:
2121842
10.

American trypanosomiasis (Chagas disease).

Rassi A Jr, Rassi A, Marcondes de Rezende J.

Infect Dis Clin North Am. 2012 Jun;26(2):275-91. doi: 10.1016/j.idc.2012.03.002. Review.

PMID:
22632639
11.
12.

[Nifurtimox, a bright future for treatment of Chagas disease].

Wolf A, Boulliat C, Coillot C, Rouault M, Gaillard K, Beranger C, Oliver M.

Med Trop (Mars). 2011 Apr;71(2):131-3. French.

PMID:
21695868
13.

Chagas disease. American trypanosomiasis.

Kirchhoff LV.

Infect Dis Clin North Am. 1993 Sep;7(3):487-502. Review.

PMID:
8254156
14.

Potential new clinical therapies for Chagas disease.

Bustamante JM, Tarleton RL.

Expert Rev Clin Pharmacol. 2014 May;7(3):317-25. doi: 10.1586/17512433.2014.909282. Epub 2014 Apr 9. Review.

PMID:
24716790
15.

Therapeutic efficacy of allopurinol in patients with chronic Chagas' disease.

Gallerano RH, Marr JJ, Sosa RR.

Am J Trop Med Hyg. 1990 Aug;43(2):159-66. Erratum in: Am J Trop Med Hyg 1991 Jun;44(6):580.

PMID:
2117857
16.

Current status of Chagas disease chemotherapy.

Guedes PM, Silva GK, Gutierrez FR, Silva JS.

Expert Rev Anti Infect Ther. 2011 May;9(5):609-20. doi: 10.1586/eri.11.31. Review.

PMID:
21609270
17.

[Evaluation of an specific treatment for Trypanosoma cruzi in children, in the evolution of the indeterminate phase].

Silveira CA, Castillo E, Castro C.

Rev Soc Bras Med Trop. 2000 Mar-Apr;33(2):191-6. Portuguese.

18.

[Therapy of the chronic phase of the experimental infection by Trypanosoma cruzi with benzonidazole and nifurtimox].

Andrade SG, Magalhães JB, Pontes AL.

Rev Soc Bras Med Trop. 1989 Jul-Sep;22(3):113-8. Portuguese.

PMID:
2518608
19.

[Recommendations for diagnosis, treatment and follow-up of the Trypanosoma cruzi: human immunodeficiency virus co-infection].

[No authors listed]

Rev Soc Bras Med Trop. 2006 Jul-Aug;39(4):392-415. Portuguese. No abstract available.

20.

Supplemental Content

Support Center